COMMUNIQUÉS West-GlobeNewswire

-
Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025
23/10/2025 -
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
23/10/2025 -
Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting
23/10/2025 -
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
23/10/2025 -
Oncotelic to present at the 2025 San Antonio Breast Cancer Symposium (SABCS) Highlighting Sapu003 (Deciparticle™ Everolimus)
23/10/2025 -
Beyond Air Schedules Second Fiscal Quarter 2026 Financial Results Conference Call and Webcast
23/10/2025 -
Grace Therapeutics Secures Approximately $4.0 Million through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for formal FDA Review
23/10/2025 -
LifeMD to Report Third Quarter 2025 Financial Results on November 6
23/10/2025 -
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
23/10/2025 -
Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors
23/10/2025 -
Crinetics to Highlight Neuroendocrine Tumor Research Progress at the 2025 North American Neuroendocrine Tumor Society Annual Meeting
23/10/2025 -
Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10ᵗʰ ESWI Influenza Conference 2025
23/10/2025 -
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
23/10/2025 -
Pacira BioSciences to Present New Data from Three Real-World Studies with EXPAREL®
23/10/2025 -
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2025 Annual Scientific Meeting
23/10/2025 -
BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society
23/10/2025 -
SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium)
23/10/2025 -
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
23/10/2025 -
Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider
23/10/2025
Pages